Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Cash Flow-to-Debt Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥233.18 Million could theoretically repay 0% of its total liabilities (CN¥2.84 Billion) in one year. See how financially flexible is Zhejiang Tianyu Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Tianyu Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Zhejiang Tianyu Pharmaceutical Co Ltd across 13 annual periods. For the full cash flow conversion analysis, see 300702 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
Year-by-year debt coverage analysis for Zhejiang Tianyu Pharmaceutical Co Ltd. Check 300702 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥473.57 Million | CN¥2.95 Billion | ▲ +43.5% |
| 2024 | 0.11x | CN¥344.64 Million | CN¥3.08 Billion | ▲ +826.2% |
| 2023 | -0.02x | CN¥-43.90 Million | CN¥2.85 Billion | ▲ +7.6% |
| 2022 | -0.02x | CN¥-48.70 Million | CN¥2.92 Billion | ▲ +86.7% |
| 2021 | -0.13x | CN¥-262.23 Million | CN¥2.09 Billion | ▼ -127.1% |
| 2020 | 0.46x | CN¥622.18 Million | CN¥1.34 Billion | ▼ -13.0% |
| 2019 | 0.53x | CN¥427.84 Million | CN¥803.09 Million | ▲ +702.0% |
| 2018 | 0.07x | CN¥78.57 Million | CN¥1.18 Billion | ▼ -38.5% |
| 2017 | 0.11x | CN¥88.52 Million | CN¥818.99 Million | ▼ -40.4% |
| 2016 | 0.18x | CN¥164.74 Million | CN¥907.72 Million | ▲ +921.9% |
| 2015 | 0.02x | CN¥14.75 Million | CN¥830.58 Million | ▼ -86.1% |
| 2014 | 0.13x | CN¥80.44 Million | CN¥628.67 Million | ▲ +66.8% |
| 2013 | 0.08x | CN¥39.73 Million | CN¥518.11 Million | — |